检索结果 - Moshe Talpaz

Refine Results
  1. 1
    Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance

    Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance 由 Dale L. Bixby, Moshe Talpaz

    出版 2009
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis

    Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis 由 Moshe Talpaz, Jean‐Jacques Kiladjian

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

    Treatment of chronic myelogenous leukemia: current status and investigational options [see comments] 由 HM Kantarjian, Susan O’Brien, Paolo Anderlini, Moshe Talpaz

    出版 1996
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia

    Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia 由 Moshe Talpaz, KB McCredie, GM Mavligit, JU Gutterman

    出版 1983
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course

    Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course 由 Razelle Kurzrock, HM Kantarjian, M Shtalrid, JU Gutterman, Moshe Talpaz

    出版 1990
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients

    Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients 由 Lee Js, DO Dixon, HM Kantarjian, MJ Keating, Moshe Talpaz

    出版 1987
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Expression of c-abl in Philadelphia-positive acute myelogenous leukemia

    Expression of c-abl in Philadelphia-positive acute myelogenous leukemia 由 Razelle Kurzrock, M Shtalrid, Moshe Talpaz, WS Kloetzer, Gutterman Ju

    出版 1987
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Chronic myelogenous leukemia: a concise update

    Chronic myelogenous leukemia: a concise update 由 HM Kantarjian, A B Deisseroth, Razelle Kurzrock, Zeev Estrov, Moshe Talpaz

    出版 1993
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Re-emergence of interferon-α in the treatment of chronic myeloid leukemia

    Re-emergence of interferon-α in the treatment of chronic myeloid leukemia 由 Moshe Talpaz, Rüdiger Hehlmann, Alfonso Quintás‐Cardama, Jessica Mercer, Jorge E. Cortés

    出版 2012
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.

    Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. 由 Moshe Talpaz, Z Estrov, Hagop M. Kantarjian, Ku S, A Foteh, Razelle Kurzrock

    出版 1994
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    TWEAK Mediates Signal Transduction and Differentiation of RAW264.7 Cells in the Absence of Fn14/TweakR

    TWEAK Mediates Signal Transduction and Differentiation of RAW264.7 Cells in the Absence of Fn14/TweakR 由 Tara C. Polek, Moshe Talpaz, Bryant G. Darnay, Taly R. Spivak-Kroizman

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia

    Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia 由 Paul J. Schilling, Razelle Kurzrock, Hagop M. Kantarjian, Jordan U. Gutterman, Moshe Talpaz

    出版 1991
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Imatinib mesylate causes hypopigmentation in the skin

    Imatinib mesylate causes hypopigmentation in the skin 由 Anne S. Tsao, Hagop M. Kantarjian, Jorge E. Cortés, Susan O’Brien, Moshe Talpaz

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways

    Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways 由 Pirkko Kellokumpu‐Lehtinen, Moshe Talpaz, David Harris, Quin Van, Razelle Kurzrock, Zeev Estrov

    出版 1996
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Therapy of chronic myelogenous leukemia with recombinant interferon- gamma

    Therapy of chronic myelogenous leukemia with recombinant interferon- gamma 由 Razelle Kurzrock, Moshe Talpaz, H Kantarjian, R S Walters, S. Saks, JM Trujillo, Gutterman Ju

    出版 1987
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Clinical investigation of human alpha interferon in chronic myelogenous leukemia

    Clinical investigation of human alpha interferon in chronic myelogenous leukemia 由 Moshe Talpaz, HM Kantarjian, KB McCredie, MJ Keating, J Trujillo, J Gutterman

    出版 1987
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemia

    Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemia 由 G Yoffe, Mark Blick, H Kantarjian, Gary Spitzer, Jordan U. Gutterman, Moshe Talpaz

    出版 1987
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction

    Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction 由 MS Lee, KS Chang, EJ Freireich, HM Kantarjian, Moshe Talpaz, JM Trujillo, SA Stass

    出版 1988
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction

    Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction 由 MS Lee, KS Chang, EJ Freireich, HM Kantarjian, Moshe Talpaz, JM Trujillo, SA Stass

    出版 1988
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction

    Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction 由 MS Lee, A LeMaistre, HM Kantarjian, Moshe Talpaz, EJ Freireich, JM Trujillo, SA Stass

    出版 1989
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: